Archives bristol-myers-squibb

by in
Entry Author Date Location
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
ASCO Roundup: Checkpoints, Pushback Against Prices, CAR-T & More 06/02/15 National
Ex-AstraZeneca Exec to Lead Surface’s “Next-Gen” Immuno-Oncology Plan 05/07/15 Boston
Adaptive Reels in Whopping $195M For Immuno-Sequencing Work 05/06/15 Seattle
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer 04/21/15 Boston
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More 04/13/15 Boston
Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal 04/06/15 New York
Pivoting From IPO, Syndax Inks Combo Trial Deal With Merck 03/31/15 Boston
East Coast Biotech Roundup: Hemophilia, Levin, Vertex, Semma & More 03/27/15 Boston
Ex-Teva CEO Levin Is Back With Startup Aimed at Rare Neuro Disorders 03/25/15 New York
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
West Coast Biotech Roundup: Pharmacyclics, Gates, Ikaria & More 03/05/15 San Francisco
“Voice for Everyone”—Life-Sci Women Talk Venture, Pharma Gender Gap 03/04/15 San Francisco
Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes 03/03/15 National
West Coast Biotech Roundup: Flexus, NGM, Illumina, Bob Klein & More 02/26/15 San Francisco
Yes to Flexus: The Science And Strategy Behind A Huge Biotech Return 02/26/15 San Francisco
Flexus Speeds From Inception to $1.25B Bristol Buyout In Less Than Two Years 02/23/15 San Francisco
Syndax CEO Says an Immuno-Oncology Thing Happened on the Way to IPO 02/17/15 Boston
Resistance Is Futile: Why That’s A Good Thing In Biomedicine 02/09/15 Seattle
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
From Yeast, Yumanity Looks to Give Rise to Critical Neuro Drugs 01/26/15 Boston
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
Surface Oncology Raises $35M to Develop Cancer Immunotherapies 01/08/15 Boston
Hepatitis C Commercial Game Theory 01/01/15 National
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
Page 1 of 11 next page »